About this blog.

This blog is a forum for disseminating the science, culture, and life of the Broad Institute. Reflecting the unique, collaborative community that is the Broad, you have the opportunity to hear from – and respond to – a variety of contributors. Click here to read our Community Guidelines.

Archives

Categories

Blog

The annual Forbes ’30 under 30’ was revealed this week, and two members of the Broad community, Cigall Kadoch and Aleksander Kostic, were named to the list. Now in its third year, ’30 under 30’ recognizes the brightest young talents in 15 different fields, including science and healthcare, technology and finance.

The Broad Institute is pleased to announce the latest class of Merkin Institute Fellows. The Broad’s first endowed fellowship, the Merkin Institute Fellows program was established in 2012 by Dr. Richard Merkin to provides sustained support for some of the most promising and ambitious scientists pursuing bold research at the Broad. The 2013-2014 recipients represent three of the Broad’s fastest rising stars: Sangeeta Bhatia, John Doench, and Angela Koehler.

Sit. Fetch. Roll-over. Humans have been trying to teach dogs for tens of thousands of years. But when it comes to the genetics of cancer, it turns out dogs have a lot to teach us, as well.

Different as we may seem, humans and dogs are genetically-speaking quite similar. Almost all canine genes have a matching gene in the human genome. Given this correlation, it’s no surprise that dogs suffer from many of the same genetic disorders as human, including cancer.

In his September 13, TEDxCambridge lecture, ‘Decoding a Genomic Revolution,’ Broad associate member and MIT associate professor Manolis Kellis used details from his own genome to demonstrate how science can bridge the gap between genetic variants and disease.

Check out the video below and accompany Kellis on a journey into his personal genome to find out how recent discoveries could change the future of medical care.

What: In one of the largest systematic analyses of schizophrenia to date, researchers from the Broad’s Stanley Center for Psychiatric Research and elsewhere identified 13 new areas of the genome linked to schizophrenia.

“Though there are still many pieces of the puzzle yet to be discovered this study provides a good collection of possible drug targets,” said co-first author Stephan Ripke.

The American Society for Biochemistry and Molecular Biology (ASBMB) has announced that Broad Institute core faculty member Aviv Regev was selected to receive the 2014 Earl and Thressa Stadtman Scholar Award. Named in honor of Earl and Thressa Stadtman—the “first family” of biochemistry—the award recognizes outstanding achievement in biochemistry and molecular biology, and consists of a cash award, a plaque, and travel expenses to the annual ASBMB meeting, where the recipient will present a featured lecture.

Update July 18: Check out a Storify of the live tweets from this event.

In the second 2013 installment of Midsummer Night’s Science, our annual public lecture series, medical oncologist and Broad associate member Levi Garraway will explore how genomic technology is helping to reveal cancer’s long-held secrets, and the many ways those findings, both the expected and unexpected, are changing the lives of patients.

Researchers in the Broad’s Epigenomics Program recently identified a key mechanism in glioblastoma, the most common and aggressive form of brain tumor. In a study published last week in Cell Reports, the team, which includes program director Brad Bernstein, revealed that certain regulatory proteins play a major role in the “self-renewing” cancer stem cells that drive glioblastoma growth.

Imagine you’re visiting the Acropolis. You tour the ruins, taking snapshots as you go. Later, at home, you tell your family and friends about your visit and someone, noticing the building’s advanced deterioration, asks: well, how did it get that way? Now, say you knew nothing about the Acropolis, and could only rely on your photos and memory to describe the place. What would you say? Without the rich archeological history of the Acropolis, you’d be missing a huge part of the story.

To convert food into energy, our bodies rely on a complex network of molecular pathways known broadly as metabolism. Along the path from food to energy, intermediate molecules emerge that form the starting materials for the next step. Traditionally, these intermediates were viewed simply as building blocks — essential for the process, but otherwise inert.